FGEN Research and Charts

FGEN - FibroGen Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-09 (Delayed quote data 2025-05-09)

Last 0.31	Change ⇓ -0.01 (0.00%)	Volume 496,557
	Open 0.32	High 0.33	Low 0.31

8EMA (Daily) 0.32	40EMA (Daily) 0.33	50EMA (Daily) 0.35	STO (Daily) 53.571	MACD Hist (Daily) 0.007
8EMA (Weekly) 0.332	40EMA (Weekly) 0.63	50EMA (Weekly) 0.88	STO (Weekly) 11.692	MACD Hist (Weekly) 0.030


Company Profile
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.